Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study Meeting Abstract


Authors: Lacouture, M.; Guillen, J.; Kudchadkar, R.; Rogers, G.; Olencki, T.; Tang, J.; Yoo, S.; Dawson, K.; Mun, Y.; Sekulic, A.
Abstract Title: Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study
Meeting Title: 18th European Cancer Conference (ECCO 18)
Journal Title: European Journal of Cancer
Volume: 51
Issue: Suppl. 3
Meeting Dates: 2015 Sep 25-29
Meeting Location: Vienna, Austria
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S675
Language: English
ACCESSION: WOS:000361887403170
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)31850-0
Notes: Meeting Abstract: 3332 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture